Hakan Harputluoğlu
Hakan Harputluoğlu publishes mostly in Oncology, Pulmonary and Respiratory Medicine and Surgery, on topics such as HER2/EGFR in Cancer Research, Cancer Treatment and Pharmacology and Lung Cancer Treatments and Mutations.
- World rank
- #1,377,659 of 7,710,434 ranked researchers
- Rank in Türkiye
- #5,497 of 117,622
- Works
- 161
- Citations
- 11k
- Citations per work
- 65.8
What does Hakan Harputluoğlu research?
Hakan Harputluoğlu's work is mostly in Medicine (62%), Biochemistry, Genetics and Molecular Biology (6%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences10062.4%
- Medicine10062.4%
- Everything else5131.8%
- Life Sciences95.8%
- 1Oncology31% of their works
- 2Pulmonary and Respiratory Medicine17% of their works
- 3Surgery6% of their works
- 4Cancer Research6% of their works
- 5Hepatology4% of their works
- 6Pathology and Forensic Medicine4% of their works
Research topics
Which keywords describe Hakan Harputluoğlu's research?
The keywords of their largest research topics: Chemotherapy, Clinical Trials, Targeted Therapy, Molecular Subtypes, Immunotherapy, Metastasis, Breast Cancer and HER2.
- Tissue of Origin
- Radiosurgery
- Small-Cell Lung Cancer
- KRAS Mutations
- Gene Expression
- EGFR Mutations
- Taxanes
- HER2
- Metastasis
- Molecular Subtypes
- Clinical Trials
- Chemotherapy
- Targeted Therapy
- Immunotherapy
- Breast Cancer
- Chemotherapy-Induced Peripheral Neuropathy
- ALK Inhibitors
- Breast Tumours
- Cetuximab
- Genomic Profiles
- Brain Metastases
- Cancer of Unknown Primary
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 22 words, with their numbers
- Chemotherapy583 topics
- Clinical Trials362 topics
- Targeted Therapy362 topics
- Molecular Subtypes352 topics
- Immunotherapy292 topics
- Metastasis282 topics
- Breast Cancer251 topic
- HER2251 topic
- Chemotherapy-Induced Peripheral Neuropathy211 topic
- Taxanes211 topic
- ALK Inhibitors201 topic
- EGFR Mutations201 topic
- Breast Tumours181 topic
- Gene Expression181 topic
- Cetuximab171 topic
- KRAS Mutations171 topic
- Genomic Profiles161 topic
- Small-Cell Lung Cancer161 topic
- Brain Metastases131 topic
- Radiosurgery131 topic
- Cancer of Unknown Primary121 topic
- Tissue of Origin121 topic
Where does Hakan Harputluoğlu work?
Hakan Harputluoğlu's main affiliation in the publication record is Inonu University, Türkiye.
How many publications and citations does Hakan Harputluoğlu have?
OpenAlex counts 161 works and 10,601 citations for Hakan Harputluoğlu, an h-index of 28, ranking #1,377,659 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Hakan Harputluoğlu. Posts are plain text and can be reported.